regulatory
confidence high
sentiment negative
materiality 0.80
NantHealth, Inc.: Nasdaq/NYSE listing notice — NantHealth receives Nasdaq delisting notice for failure to meet public float requirement
NantHealth, Inc.
- Received Nasdaq notice on May 2, 2023 that common stock will be suspended on May 11, 2023 due to non-compliance with $15M public float requirement.
- Company intends to request a hearing by May 9, 2023, which will stay suspension pending Nasdaq hearing process.
- Previously disclosed deficiency from October 31, 2022; compliance period ended May 1, 2023.
- Stock continues to trade on Nasdaq Global Select Market under symbol NH during the appeal process.